Seach Medical Group Income Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	157.15	171.72	150.32	134.21	67.34
Revenue Growth (YoY)	-8.48%	14.24%	12.01%	99.30%	82.98%
Cost of Revenue	110.31	114.09	112.93	95.91	44.34
Gross Profit	46.85	57.63	37.4	38.3	23
Selling, General & Admin	33.68	37.75	38.23	32.74	16.16
Research & Development	0.8	0.98	1.76	1.45	2.31
Other Operating Expenses	0.09	-0.05	-0.23	0.08	0.12
Operating Expenses	34.58	38.67	39.76	34.27	18.59
Operating Income	12.27	18.96	-2.37	4.03	4.41
Interest Expense	-1.8	-1.45	-1.81	-0.94	-0.17
Interest & Investment Income	-	0.39	0.25	0.01	0.25
Earnings From Equity Investments	-0.02	-0.27	0.19	-1.24	-1
Other Non Operating Income (Expenses)	1.13	-0.81	-0.87	-0.73	-0.25
EBT Excluding Unusual Items	11.58	16.83	-4.61	1.14	3.24
Impairment of Goodwill	-8.04	-2.27	-5.76	-	-
Gain (Loss) on Sale of Investments	0.44	0.04	-2.03	-5.04	0.49
Gain (Loss) on Sale of Assets	-	0.02	-0.32	-0.17	0.01
Asset Writedown	-	-1.38	-	-	-
Other Unusual Items	-	0.2	2.44	0	2.49
Pretax Income	3.99	13.42	-10.28	-4.07	6.23
Income Tax Expense	3.63	-0.14	1.59	1.2	1.01
Earnings From Continuing Operations	0.35	13.56	-11.87	-5.27	5.23
Minority Interest in Earnings	1.17	-0.03	1.36	1.86	0.12
Net Income	1.52	13.52	-10.51	-3.41	5.35
Net Income to Common	1.52	13.52	-10.51	-3.41	5.35
Net Income Growth	-88.73%	-	-	-	-55.30%
Shares Outstanding (Basic)	30	34	34	34	34
Shares Outstanding (Diluted)	30	34	34	34	34
Shares Change (YoY)	-10.44%	0.03%	-	0.78%	3.61%
EPS (Basic)	0.05	0.40	-0.31	-0.10	0.16
EPS (Diluted)	0.05	0.40	-0.31	-0.10	0.16
EPS Growth	-87.42%	-	-	-	-56.86%
Free Cash Flow	16.44	15.54	-0.67	16.16	-10.02
Free Cash Flow Per Share	0.54	0.46	-0.02	0.47	-0.30
Dividend Per Share	-	0.120	-	-	-
Gross Margin	29.81%	33.56%	24.88%	28.54%	34.16%
Operating Margin	7.81%	11.04%	-1.57%	3.00%	6.55%
Profit Margin	0.97%	7.88%	-6.99%	-2.54%	7.94%
Free Cash Flow Margin	10.46%	9.05%	-0.44%	12.04%	-14.88%
EBITDA	14	21.27	1.29	9.28	7.39
EBITDA Margin	8.91%	12.38%	0.86%	6.92%	10.97%
D&A For EBITDA	1.72	2.31	3.66	5.25	2.98
EBIT	12.27	18.96	-2.37	4.03	4.41
EBIT Margin	7.81%	11.04%	-1.57%	3.00%	6.55%
Effective Tax Rate	91.14%	-	-	-	16.14%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.